Our findings demonstrate that MCM7 is upregulated in clinical samples of ccRCC, and its inhibition reduces cellular proliferation and caspase-3/7 activity in RCC cells, confirming its oncogenic potential. This evidence concerns the gene MCM7 and nonpapillary renal cell carcinoma.